Natural language processing technology developer Bloomsbury AI has joined Facebook for up to $30m, enabling UCL Technology Fund to exit.

The business management platform, which had raised $700m from investors including Salesforce and WPP, floated near the top of its range.

The cancer drug developer and Stanford spinout floated at the top of its range in an offering that could reach $129m.

Efficient Drivetrains, which had amassed $17.5m in capital, makes drivetrain systems for electric and hybrid-powered automotive vehicles based on research from UC Davis.

Precision oncological diagnostics developer Clearbridge BioMedics is planning to float, almost a decade after it was spun out from National University of Singapore and Smart Centre.

The Tencent-backed group buying platform has filed to list in the US having raised almost $2.4bn in funding over the past year.

Leeds spinout Escubed has gone into administration having racked up payable debts worth $255,100 by the end of July 2017.

Access Industries and Pharmstandard-backed immuno-oncology therapy developer Neon Therapeutics floated in the middle of its range.

Babytree has filed for an initial public offering in Hong Kong, three weeks after Alibaba acquired a reported 10% stake in the e-commerce platform.